Scorpius Holdings Inc - Company Profile

Powered by

All the sales intelligence you need on Scorpius Holdings Inc in one solution.

$195 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Scorpius Holdings Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Scorpius Holdings Inc.

Back to companies

Scorpius Holdings Inc: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Scorpius Holdings Inc (Scorpius), NightHawk Biologics Inc, was a contract development and manufacturing organization (CDMO). Following the sale of its assets the company is classified as a "shell company". It is headquartered in Morrisville, North Carolina, the US.

 Gain a 360-degree view of Scorpius Holdings Inc and make more informed decisions for your business Gain a 360-degree view of Scorpius Holdings Inc and make more informed decisions for your business Learn more
Headquarters United States of America
Address Suite 300, 627 Davis Drive, Morrisville, North Carolina, 27560
Website ir.scorpiusbiologics.com
Telephone 1 302 6365400
No of Employees 89
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange SCPX (OTC)
Revenue (2023) $6.2M -10.7% (2023 vs 2022)
EPS XYZ
Net Income (2023) XYZ 27.4% (2023 vs 2022)
Market Cap* $80,000
Net Profit Margin (2023) XYZ 18.7% (2023 vs 2022)
* As of and is in US$
View Scorpius Holdings Inc financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Learn more

Scorpius Holdings Inc premium industry data and analytics

20+

Pipeline Drugs

Identify which of Scorpius Holdings Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

20+

Clinical Trials

Determine Scorpius Holdings Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

17+

Catalyst Calendar

Proactively evaluate Scorpius Holdings Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

5

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

4

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

1

Marketed Drugs

Understand Scorpius Holdings Inc’s commercialized product portfolio to stay one step ahead of the market.

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2025 Divestiture In December, the company sold the manufacturing and development assets to Tivic Health Systems.
2025 Contracts/Agreements In January, the company collaborated with KaloCyte to advance manufacturing for ErythroMer.
2024 Contracts/Agreements In January, the company entered into a patent rights sale and assignment agreement with Kopfkino IP, LLC for certain provisional patent applications.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Learn more
Image for loader
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Learn more
Executives
Name Position Board Since Age
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Scorpius Holdings Inc key executives to enhance your sales strategy Gain insight into Scorpius Holdings Inc key executives to enhance your sales strategy Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?